MAKO Surgical, a medical device company focused on minimally invasive orthopedic knee procedures, lowered the expected price range on its 5.1 million share offering in a filing with the SEC on Thursday. The company now expects the offering price to be between $10 and $11, 30% lower than the original $14 to $16 range at the midpoint. JP Morgan and Morgan Stanley are the joint book runners on the deal.
